These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 9074515

  • 1. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I.
    J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
    [Abstract] [Full Text] [Related]

  • 2. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Mar; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 3. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 4. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 Nov; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 7. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
    Spanu A, Solinas ME, Farris A, Arru A, Chessa F, Madeddu G, Falchi A, Madeddu G.
    Radiol Med; 2004 Nov; 107(1-2):113-27. PubMed ID: 15031703
    [Abstract] [Full Text] [Related]

  • 8. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 9. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases.
    Nishiyama Y, Yamamoto Y, Ono Y, Takahashi K, Nakano S, Satoh K, Ohkawa M, Tanabe M.
    Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332
    [Abstract] [Full Text] [Related]

  • 10. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy.
    Kresnik E, Gallowitsch HJ, Mikosch P, Molnar M, Pipam W, Gomez I, Lind P.
    Eur J Nucl Med; 1997 Jul; 24(7):716-21. PubMed ID: 9211755
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

  • 16. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T, Tsukamoto E, Nakada K, Morita K, Kato T, Mabuchi M, Yoshinaga K, Katoh C, Kuge Y, Tamaki N.
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [Abstract] [Full Text] [Related]

  • 17. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D, Mazzarotto R, Casara D.
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [Abstract] [Full Text] [Related]

  • 18. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
    Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G.
    J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
    [Abstract] [Full Text] [Related]

  • 19. Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Wu HS, Liu FY, Huang WS, Liu YC, Chang CT, Kao CH.
    Clin Radiol; 2003 Oct; 58(10):787-90. PubMed ID: 14521888
    [Abstract] [Full Text] [Related]

  • 20. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
    Gallowitsch HJ, Kresnik E, Mikosch P, Pipam W, Gomez I, Lind P.
    Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.